ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· signalscv.com, Wayback capture

SCVBJ

Valencia Technologies of SCV Given 2015 Patrick Soon-Shiong Innovation Award

Valencia Technologies Corporation was selected as one of five recipients of the 2015 Patrick Soon-Shiong Innovation Awards in late November.

The firm was awarded for its coin-sized bio-electronic device for the treatment of major chronic conditions including high blood pressure.

Valencia Technologies created a device it termed as being “radically small” when profiled in the Santa Clarita Valley Business Journal in 2014. The firm’s device is implanted into the patient in a simple procedure in a doctor’s office.

The company has secured 11 patents and in 2014 opened its books, intellectual property as the company planned to launch one of the first authorized crowd funding campaigns from accredited investors only per Securities and Exchange Commission rules that went into effect that year. The company set out to raise $30 million.

Launched in 2011 by Jeff Greiner, who was formerly with Advanced Bionics, the firm found a body of literature that showed just 30 minutes of stimulating the brain per week was enough for the brain to remap or remodel itself, keeping hypertension at bay.

In essence, the biomedical firm challenged the assumption of other medical devices in the field that the stimulation needs to be continuous. Double-blinded clinical trials showed a significant change in a person’s hypertension.

Billionaire medical entrepreneur Patrick Soon-Shiong is a Los Angeles-based surgeon, medical researcher, businessman and philanthropist. He made a fortune developing an important cancer drug.

The event was hosted by the Los Angeles Business Journal. Greiner said his firm was “truly humbled and grateful for this recognition as Patrick Soon-Shiong is one of the world’s most important visionaries in the field of healthcare.”

“We’ve built a culture of innovation at Valencia by recruiting the top creators in our field, by publicly praising and rewarding their inventions, by encouraging open discussions where the purpose is to get the best solution, and by appreciating deeply that patients’ lives are improved through fearlessness and imagination,” Greiner said in a statement.

The device will be tested for the treatment of resistant hypertension in a trial to begin early 2016.

Image not recovered01_BJ_Valencia-Technologies_KL_02_web.jpg

← Back to 2015

About this record

How it was held, read and classified

Record details

Morris ID
146772
System
Morris section CMS (/section/…/article/… and /archives/…)
Reading copy
signalscv.com
Chosen by: only copy held. On this copy: words 341 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 1.
Extracted by
section_cms:articlebody_span
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:section_24_local
  • text:valley_names [3 distinct/6 mentions: Santa Clarita, SCV, Valencia]
  • byline:named_writer_no_wire_credit [By Jana Adkins]
National signals
none fired
Scores
local 7, national 0